A Landscape Review of ALS Therapy Development
3:50 pm - Wednesday 3rd June 2026
- The drug landscape, displaying critical data-driven therapeutic and clinical trial highlights, as well as current trends
- A look at the developer landscape, allowing for understanding of the commercial market involving these drugs’ development
- The outlook for the future of the ALS therapeutics field from a preclinical and clinical perspective
